Director’s Dealing
Executive Chairman purchased 84,033 shares at 11.9 pence per share on 26 March 2025.
Select text to share a quote on X · sign in to keep highlights & notes in your SAR notes
Cambridge, UK, 27 March 2025 - Sareum Holdings plc (AIM: SAR), a clinical-stage biotechnology company developing next-generation kinase inhibitors for autoimmune disease and cancer, announces that Dr Stephen Parker, Executive Chairman, purchased 84,033 ordinary shares of 1.25 pence each in the capital of the Company ("Ordinary Shares") at an average price of 11.9 pence per share on 26 March 2025.
In addition, persons connected with Dr Parker are interested in a further 25,680 Ordinary Shares in the Company, over which Ordinary Shares Dr Parker has voting rights discretion.
Therefore, following the transaction, Dr Parker has direct and indirect interests in an aggregate 405,045 Ordinary Shares in the Company, representing approximately 0.30 per cent. of the Company's currently issued share capital.
The notification below, which has been made in accordance with the requirements of the Market Abuse Regulation, provides further details.
PDMR Notification Form:
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |
| a) | Name | Stephen Parker |
| 2 | Reason for the notification | |
| a) | Position/status | Executive Chairman |
| b) | Initial notification/amendment | Initial notification |
| a) | Name | Sareum Holdings plc |
| b) | LEI | 213800PKERN2DY8FFM72 |
| a) | Description of the financial instrument, type of instrument | Ordinary shares of 1.25 pence each in the share capital of Sareum Holdings plc |
| Identification code | GB00B02RFS12 | |
| b) | Nature of the transaction | Purchase of shares |
| c) | Price(s) and volume(s) | |
| Price(s) | Volume(s) | |
| £0.119 | 84,033 | |
| d) | Aggregated information | |
| - Aggregated volume | 84,033 Ordinary Shares | |
| - Weighted Average Price | 11.9 pence per Ordinary Share | |
| e) | Date of the transaction | 26 March 2025 |
| f) | Place of the transaction | London Stock Exchange (AIM) |
596/2014, which is part of UK law by virtue of the European Union (Withdrawal) Act 2018.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.